The Latest Breaking News from Raghuram Selvaraju

Ultragenyx Represents 'Intriguing Buying Opportunity,' Despite Recent Setbacks

HC Wainwright assumed coverage on Ultragenyx Pharmaceuticals, Inc. (NASDAQ:RARE) on Monday, representing an attractive opportunity at current levels.

Benzinga · Jul 28, 2025

What Analysts Are Saying About Rockwell Medical Stock

Ratings for Rockwell Medical (NASDAQ:RMTI) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga · Nov 25, 2024

A Glimpse Into The Expert Outlook On Rhythm Pharmaceuticals Through 13 Analysts

Rhythm Pharmaceuticals (NASDAQ:RYTM) has been analyzed by 13 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga · Nov 25, 2024